Biochemical Markers of Subclinical Atherosclerosis in Patients with Type 2 Diabetes Mellitus
<strong>Background:</strong> insulin resistance and associated metabolic alterations, such as dyslipidemia, hypertension, obesity and hypercoagulability, influence the increasingly premature appearance and severity of atherosclerosis that patients with diabetes mellitus develop. <br /...
Saved in:
Main Authors: | Caridad Osorio Sosa (Author), Leonar Luis Nápoles Acosta (Author), Alfredo Salvador Vallés Gamboa (Author), Alberto Caballero Laguna (Author) |
---|---|
Format: | Book |
Published: |
Universidad de las Ciencias Médicas de Cienfuegos,
2022-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Subclinical Atherosclerosis in Young Adult Population with First Degree Relatives of Type 2 Diabetes Mellitus
by: Muhammad Syah Abdaly, et al.
Published: (2019) -
Effects of subclinical hypothyroidism in type II diabetes mellitus patients on biochemical, coagulation, and fibrinolysis status
by: Yasir Abbas Atia, et al.
Published: (2024) -
Insulin metabolism markers are predictors of subclinical atherosclerosis among overweight and obese children and adolescents
by: Golaleh Asghari, et al.
Published: (2018) -
Immune Activation, Immunosenescence, and Osteoprotegerin as Markers of Endothelial Dysfunction in Subclinical HIV-Associated Atherosclerosis
by: Alessandra D'Abramo, et al.
Published: (2014) -
Visfatin and adiponectin as early markers of atherosclerosis in type 2 diabetes mellitus
by: Ibtissam Zakaria, et al.
Published: (2013)